Streamlined cell line development
IDBS cut cell line development reporting timelines by 50%. It supports hundreds of users globally at a biotechnology company focusing on biologic therapeutics.
IDBS cut cell line development reporting timelines by 50%. It supports hundreds of users globally at a biotechnology company focusing on biologic therapeutics.
Find out how to curate the data you need to tackle biopharma’s biggest challenges.
IDBS Polar BioAnalysis could cut your bioanalytical study time by over 55%
Find out how to curate the data you need to tackle biopharma’s biggest challenges.
Janssen looks at external and internal data sharing as a win-win application of digital technology that enables external manufacturers to perform optimally, while sponsor companies benefit from enhanced reliability, lower cost and better assurance of quality.
Find out how to curate the data you need to tackle biopharma’s biggest challenges.
Discover the practices to achieve the level of process knowledge required for successful technology transfer and how they are preparing for the shift from static tech transfer to dynamic, persistent and compliant knowledge sharing.
Learn the importance of enterprise control in getting CGTs to market – and the critical systems that enable this control in cell-based therapy manufacturing.
From ensuring data integrity to consolidating IP ownership, effective data management is key for BioPharma companies seeking a competitive edge.
Join us on the 30th November, to discuss best practices for addressing this challenge and explore the use of innovative solutions to streamline process data management with higher data integrity, support accelerated tech transfer between development and manufacturing, and drive collaboration among internal and external teams.